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Abstract
Drug development is a tedious process involving a huge amount of time and money. Clinical
trials are the important part of the drug development process. In clinical trials, subject
recruitment is challenging especially when recruiting the Generation Y (millennial) population
group. This might be generational or due to few barriers. In the present research, in-class surveys
were done in the College of Health and Human Services and the College of Business at Eastern
Michigan University to determine whether an educational intervention impacts the willingness of
Generation Y to participate in clinical research. This interventional group (active group or
exposure group) was compared to a placebo group (without any educational intervention). In
both treatment groups, the number of students who were willing to participate in clinical trials
was > 90%. This clearly indicates that the intervention used did not work, or it simply means that
the students are willing to participate in clinical trials. Between Generation Y (n = 114) and the
35 years or older group (n = 2), far more of Generation Y, almost 98.3%, indicated that they
were willing to participate in clinical research. This trend might be different if the sample size
were similar. When asked “How knowledgeable are you about clinical research?” participants
with science backgrounds clearly indicated more knowledge than non-science professions. Three
quarters of participants said they have complete knowledge about clinical research, but upon
further analysis it was seen that they answered incorrectly when asked what clinical research is.
Therefore, further research is needed on these parameters with a better exposure of the treatment
group and with equal sample size in both the comparing groups, since the number of participants
older than 35 years in the present study was too limited to make any reliable conclusions.
Keywords: Clinical trials, Generation Y, interventional group
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Chapter 1: Introduction
Clinical research, or clinical trials, is research done on humans to determine the safety and
effectiveness of new medicine. According to the World Health Organization (2015):
A clinical trial is any research study that prospectively assigns human participants or
groups of humans to one or more health-related interventions to evaluate the effects on
health outcomes. Interventions include but are not restricted to drugs, cells and other
biological products, surgical procedures, radiological procedures, devices, behavioral
treatments, process-of-care changes, preventive care, etc. (para. 1)
Therefore, as per World Health Organization, a clinical trial enrolls humans to study the results
of a given product or procedure. Friedman, Furberg, and DeMets (2010), in the The
Fundamentals of Clinical Trials (4th ed.), stated, “Clinical trial is a prospective study comparing
the effect and value of intervention(s) against a control in human beings” (p. 2). To conduct
clinical research, human beings (healthy volunteers or specific patient populations) are to be
screened and enrolled in a study based on inclusion and exclusion criteria. Patient or subject
recruitment into clinical trials is done at clinical sites, using various recruitment strategies
approved by the site institutional review board (IRB) or institutional ethical committee (IEC).

Students’ Willingness to Participate in Clinical Trials
Chapter 2: Background
Trauth, Musa, Siminoff, Jewell, Ricci (2000), stated that the general public understands
that biomedical research unfolds new, safe, and effective ways to diagnose, treat, and cure
diseases, but they are not aware of the fact that this advancement takes place only with public
participation. According to Moorcraft et al. (2016), “Recruiting subjects can be challenging and
slower than anticipated.” Subject recruitment is a major challenge in clinical trials, especially
with the subjects between the ages of 18 and 34 years, termed Generation Y (Nelson, Martin, &
Getz, 2015). This can be challenging because of barriers such as attitude, religious factors, and
knowledge (Brown, Cowdery, & Jones, 2015). Brown et al. (2015) conducted a questionnaire
survey of about 82 Michigan high school students and studied how “knowledge” and “attitude”
of adolescence affect their participation in clinical trials. The researchers made race/ethnic
comparisons to see if educational intervention can make any difference. According this survey,
only 33% had heard about clinical trials, and overall understanding about clinical trials was
below average (46%). Minority students had low knowledge (p = .0006), a more negative attitude
(p = .05), and more distrust (p = .15) about the clinical trials than non-Hispanic Whites, whereas
non-Hispanic Whites (p = .05) had more self-efficacy. In this survey, participants indicated that
they felt more positive towards participating in clinical trials. Therefore, the authors stated that
educational intervention is needed to deal with barriers such as knowledge, attitude, and a
distrust among adolescents, which may increase their awareness and willingness to participate in
clinical trials.
According to Midgley, Isaacs, Weitkamp, Target (2016), “Relatively little research is
available on young people’s participation in clinical trials generally,” and when done, two things
should be considered: (a) that important terminology such as “recruitment, randomization, and
2
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ongoing data collection” is understood, and (b) whether participating in the trial impacted their
therapy/treatment (p. 2).
In Winter 2015, an email survey was conducted on active students attending Eastern
Michigan University to understand the college-aged population’s knowledge of common
terminologies used in informed consent forms when enrolling as subjects in clinical trials
(Garapati, 2015). Most of the college-aged population couldn’t differentiate between clinical
research and clinical laboratory practices. Only 45.1% answered correctly when asked, “What is
clinical research or clinical trials?”. And only 42.2% selected all the options that apply when
asked, “Where clinical research studies are conducted”.
Based on the email survey results of these two questions, the present study tried to further
estimate college-aged students’ understanding and willingness to participate in clinical research
through an in-class paper survey. In the present survey, the age groups were 18–24 years, 25–34
years, and 35 years or older. For most of the analysis, 18–24 and 25–34 years were collapsed to
18–34 years, which represents the Generation Y population in the survey. Any participants 35 or
older were considered Generation X.
Generation Y is not clearly explained in the literature, but according to Strauss and Howe
(1991), who first coined the term, it is defined as those born between 1982 and 2004. Therefore,
the age group that falls under Generation Y (millennials) is 13–34 years, whereas Generation X
would include those born prior to 1982, and Generation Z includes those born after 2005.
According to Nelson et al. (2015), Generation Y are less likely to participate in clinical trials
than those of older groups. The authors further stated that this difference is considered
generational and not simply related to age.
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Brown et al. (2015) conducted a survey to understand the knowledge and attitudes of
adolescents towards clinical trials. The authors categorized the survey questions based on
barriers such as distrust of medical research, attitudes, knowledge, perceived ability, receptivity,
and intention about clinical research. Based on their results, the authors concluded that
educational interventions aimed at adolescents may improve clinical trial awareness and can
address some of the barriers that inhibit young people from enrolling in clinical trials.
Purpose of the Study
The purpose of this study is to influence the willingness of Generation Y to participate in
clinical research by providing a minimal amount of education prior to completion of a
questionnaire.
Research Question
1. Does a better understanding of clinical research affect Generation Y’s willingness to
participate in clinical trials?
2. Does the college of Health and Human Services have better understanding than
College of Business?
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Chapter 3: Research Design and Methodology
After receiving approval from the University Human Subjects Review Committee at
Eastern Michigan University (Appendices A and B), an in-class paper survey was conducted in
the Spring 2016 semester. Members of two colleges of undergraduate students at Eastern
Michigan University were selected, and individual departments were approached for permission
to conduct the survey. This paper includes a detailed analysis of surveys done in the College of
Health and Human Services and the College of Business. In the College of Health and Human
Services, one undergraduate class was selected (n = 118), and in the College of Business, five
undergraduate classes were approached (n = 92). The survey sheets used were color-coded by
college. In each class, students were given either a survey sheet that had a small description of
drug development (Active Group; see Appendix C) or a survey sheet that had a standard
scientific method definition (Placebo Group; see Appendix D). The survey sheets contained 12
questions that included those related to clinical research and student demographics such as age,
gender, college year, and academic major. Students in each class were given these sheets (active
or placebo) randomly. Students were informed verbally (Verbal Consent Form; see Appendix E)
that they could return the survey sheets filled or blank as per their willingness to participate in
the survey. (This was considered the consent to participate in the in-class paper survey.)
Collected data from the in-class paper survey were initially entered into Microsoft Excel.
Later these data were translated to SPSS format, in which each question and their options
(answers) were categorized into ordinal or nominal (dichotomous, multi-nominal) data. The
translated data were analyzed in SPSS v24 to get cross-tabulations on demographics and other
possible parameters that better answer the research question. A Fisher’s exact and Pearson chisquare testing was done to evaluate the data accordingly to get suitable cross tabulations and p5
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values to check the statistically significant association between the comparing variables.
Descriptive analysis was also done to compare each question in the survey with individual
demographic data available.

6

Students’ Willingness to Participate in Clinical Trials
Chapter 4: Results
The present survey included detailed analysis of 210 respondents, where 118 (56.19%)
were from College of Health and Human Services (HHS) and 92 (43.80%) from the College of
Business (COB). Of these respondents, 109 (51.90%) were provided with an active survey sheet
and 101 (48.09%) with the placebo survey sheet. Eleven respondents were completely eliminated
from the sample, as they indicated that their majors were from more than one college (e.g., from
both COB and HHS or COT and COB), and no further analysis was done on this excluded
population.
A descriptive analysis of demographic data (counts and percentages) for all of the
students who participated in the survey is presented in Table 1.
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Table 1
Demographics: HHS and COB
Demographics

Groups

n

Percentages

Age

18-24 years

144

68.57%

25-34 years

57

27.14%

35 or older

8

3.80%

Missing

1

0.47%

Female

131

62.38%

Male

75

35.71%

Prefer not to answer

4

1.90%

First

15

7.14%

Second

33

15.71%

Third

94

44.76%

Fourth

57

27.14%

Graduate

10

4.76%

Missing

1

0.47%

HHS

118

56.19%

COB

92

43.80%

Gender

College year

Majors
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When the question “How knowledgeable are you about clinical research?” was asked of
210 respondents to assess the knowledge they believe they have about clinical research, 17.61%
(n = 37) said they are not at all knowledgeable, 54.28% (n = 114) checked a little
knowledgeable, 26.19% (n = 55) checked somewhat knowledgeable and just 1.90% (n = 4) said
they are they completely knowledgeable. (See Table 2.)
Table 2
Participant Knowledge About Clinical Trials
Not at all

A little

Somewhat

Completely

knowledgeable knowledgeable knowledgeable knowledgeable
Students (n = 210)

17.61% (n = 37) 54.28% (n = 114) 26.19% (n = 55) 1.90% (n = 4)

When chi-square analysis was performed on the first question, “How knowledgeable are
you about clinical research?” with age parameter, the association of these variables was not
significant (χ2(1) = 9.54, df = 6, p = .145). Among those 18–24 years, 20.8% (n = 30) checked
not at all knowledgeable, 56.9% (n = 82) checked a little knowledgeable, 20.8% (n = 30)
checked somewhat knowledgeable, and 1.4% (n = 2) checked completely knowledgeable. Among
those 25–34 years, 12.3% (n = 7) checked not at all knowledgeable, 47.4% (n = 27) checked a
little knowledgeable, 36.8% (n = 21) checked somewhat knowledgeable, and 3.5% (n = 2)
checked completely knowledgeable. Among those 35 or older, 0% checked not at all
knowledgeable, 62.5% (n = 5) checked a little knowledgeable, 37.5% (n = 3) checked somewhat
knowledgeable and 0% chose completely knowledgeable. (See Figure 1.)
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Figure 1. Participants’ knowledge about clinical trials vs. age groups.
Nelson (2015) defined millennial as those aged 18–34 years in the Center for Information
and Study on Clinical Research Participation (CISCRP). The response from the groups when age
variable was collapsed (18–24 and 25–34 years as 18–34 years) and compared to 35 or older is
presented in Figure 2.

Figure 2. Generation Y (18–34 years) vs. Generation X (35 or older) about clinical trials.
Figure 2 shows more Generation Y (18–34 years) respondents than Generation X, and
most of age 18–34 year participants listed themselves as a little knowledgeable.
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Figure 3. Participants’ majors vs. their knowledge of clinical trials in two groups.
Health and Human Services majors rated their knowledge as more at a higher percentage
in both treatment groups than participants from the College of Business (Figure 3).

Figure 4. Academic major response compared with knowledge of participants.
When a Fisher’s exact test was done to compare students’ academic majors and how
knowledgeable they are about clinical research, it indicated a statistically significant association
(p < .001, Pearson Chi-square = 27.66, df = 3). Out of 118 HHS participants, only 6.8% said they
were not at all knowledgeable, 55.1% said they are a little knowledgeable, 35.6% said they are
somewhat knowledgeable, and 2.5% said they were completely knowledgeable. Of 92 COB
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participants, 31.5% said they were not at all knowledgeable, 53.3% said they were a little
knowledgeable, 14.1% said they were somewhat knowledgeable, and 1.1% said they were
completely knowledgeable (Figure 4).
The participants were asked a multiple-choice question with four possible responses, one
of which contained the correct definition of clinical research or clinical trials. Of 210
participants, only 38.09% (n = 80) correctly defined clinical research as scientific investigations
using humans to study treatment of human disease. Of the rest, 8.09% (n = 17) thought that
clinical research was scientific investigations using animals to study treatment of human disease,
36.1% (n = 76) thought that clinical research was scientific investigations using laboratory
studies to study treatment of human disease, and 8.5% (n = 18) were not sure; the remaining 10%
1.42% (n = 3) thought they were tests done on humans and animals; 6.66% (n = 14) thought they
were done on humans, animals, and in laboratories; and 0.95% (n = 2) thought they were done on
humans and through laboratory studies. There is only one correct answer to this question, but a
few students chose multiple options.
An exact chi-square testing was conducted to compare correct and incorrect responses for
the definition of clinical research or clinical trials with treatment groups, and there was no
statistically significant impact of the treatment group on correct response, χ2(1) = 0.022, p = .88.
Among the placebo group, 61.4% (n = 62) answered incorrectly, and 38.6% (n = 39) answered
correctly, whereas among the active group, 62.4% (n = 68) answered incorrectly, and 37.6% (n =
41) answered correctly.
When comparing the treatment group with correct and all incorrect responses, of 101
placebo group participants, 61.4% answered incorrectly, and 38.6% selected the correct answer.
However, of 109 active group participants, 62.4% gave an incorrect response and only 37.6%
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gave a correct response, with a p = .88, indicating no association and no statistically significant
impact of the treatment group on the correct response.
Figure 5 shows responses by academic year for the correct response for Question 2 from
the survey.

Figure 5. Correct response to clinical research/clinical trials by students of different college
years in the HHS and COB in both treatment groups.
The trend of giving the correct response did not increase with academic standing/college
years. Among HHS students (p = .22), 1.4% of first-year, 15.7% of second-year, 48.6% of thirdyear, 28.6% of fourth-year, and 5.7% of graduate students answered Question 2 incorrectly. On
the contrary, 0% of first-year, 29.8% of second-year, 51.1% of third-year, 14.9% of fourth-year,
and 4.3% of graduate students answered correctly. However, among COB student participants (p
= .23), 16.9% of first-year, 5.1% of second-year, 37.3% of third-year, 33.9% of fourth-year, and
6.8% of graduate students answered incorrectly. Only 12.1% of first-year, 15.2% of second-year,
13
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42.4% of third-year, 30.3% of fourth-year, and 0% of graduate students answered correctly.
When exact chi-square testing (p = .48, χ2(1) = 27.66, df = 3) was done on participants to
compare the correct response to questions on clinical research definition and how knowledgeable
they were about clinical research, the ones who said they were completely knowledgeable
answered incorrectly when asked the definition of clinical research. (The sample size for that
group is disproportionately low.) See Table 3.
Table 3
Clinical Research Definition vs. How Knowledgeable About Clinical Research?

Correct responses on
clinical research

Not at all
knowledgeable
% (n)

A little
knowledgeable
% (n)

Somewhat
knowledgeable
% (n)

Completely
knowledgeable
% (n)

definition
Incorrect Response

70.3 (26)

62.3 (71)

54.5(30)

75.0(3)

Correct Response

29.7(11)

37.7(43)

45.5 (25)

25.0 (1)

When the chi square test was done to compare “willingness to participate in clinical
trials” with “age” (p = .063, χ2(1) = 3.44, df = 1), among the active group (n = 108), of the 57
participants who answered yes, all were from the 18–34 years age group, and of 51 participants
who answered no, 48 (94.1%) were from the 18–34 years age group, and 3 (5.9%) were from the
35 or older age group. In the placebo group (n = 100), of the total 59 participants who answered
yes, 57 (96.6%) were from the 18–34 year old age group, and 2 (3.4%) were from 35 or older age
group. Of the 41 participants who answered no, 37 were from the 18–34 years age group, and 5
were from the 35 or older age group, with no statistically significant association (p = .37, χ2(1) =
14
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0.785, df = 1).
When the Pearson chi-square test was performed, 53.2% (n = 58) of 108 active group
participants said yes, they are willing to participate in clinical research, and 46.8% (n = 51) said
no. Out of 100 placebo group participants, 59% (n = 59) said yes and 41% (n = 41) said no,
without a statistical significant association (p = .4, χ2(1) = 0.709, df = 1).
The Pearson chi-square test was done on academic majors and willingness to participate,
Question 3 from the survey sheet (p = .017, χ2(1) = 5.696, df = 1).
Table 4
Willingness to Participate in Clinical Trials
Willingness to participate in the
clinical research

Yes
% (n)

No
% (n)

63.2 (74)

46.7 (43)

College of Health & Human
Services
College of Business

36.8 (43)

53.3 (49)

Table 5 lists reasons given to participate and not to participate in clinical trials by the
enrolled students within this survey.
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Table 5

Table 6

Reasons for Participating in Clinical Trials

Reasons for not Participating in Clinical Trials
Reason for not participating

n(%)

I do not want to be used as a guinea pig

27
(10.93)

54 (18.75)

I do not know if it would be safe

111
(44.93)

An interesting thing to do

43 (14.93)

I simply prefer not to

26
(10.52)

To get help with my illness

66 (22.91)

I am concerned about taking an
experimental drug

83
(33.60)

Reason for participating

n(%)

If I get paid

125 (43.40)

To help future generations

When enrolled students were asked if they would take a drug that was not tested on
animals or humans, 197 out of 208 (94.7%) said no and 5.3% said yes. Two responses are
missing as they did not answer this question.
When a question “How a participant prefers be informed of an active clinical trial?” was
asked, 67% of participants chose “From a Physician” and 6% chose “Through Facebook or other
social media” (Figure 6).
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Figure 6. How a participant prefers to be informed of an active clinical trial.
When “Where do you think clinical research is conducted?” was asked, the highest
percentage of participants chose “University Medical Centers” (See Table 7).
Table 7
Where Clinical Research Was Conducted
Hospitals

University
Clinics
Medical Centers

28.85%

34.45%

19.01%

Private
Physicians’
Offices
9.39%

Not sure
8.3%

17
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Chapter 5: Discussion
Clinical research studies are done at various medical sites (hospitals, university medical
centers, clinics, and private physicians’ offices). These studies enroll diverse sets of the
population. In the present survey, EMU students were asked 12 questions, four of which were
related to the demographics of the sample. Of the other eight questions asked, the main aim was
to understand how the intervention of the paragraph about “drug development” in active survey
sheets and a paragraph about “scientific method” in the placebo group affected the pattern of
students’ responses to the survey questions and their willingness to participate in clinical
research. The College of Health and Human Services (HHS) major students who participated
clearly indicated that they have more knowledge about clinical research than participants from
the College of Business (COB), with a statistically significant association, a p < .001 (Figure 4).
When exact chi-square testing was done to determine how knowledgeable participants were
about clinical research with “What is clinical research?” 75% who said they had complete
knowledge gave an incorrect response (Table 3). However, here the sample size is
disproportionately low (completely knowledgeable was selected by just three participants).
However, among other participants who chose incorrectly, 70.3% said they were not at all
knowledgeable, 62.3% said they were a little knowledgeable, and 54.5% said they were
somewhat knowledgeable (p = .44). This analysis clearly indicates that the students assessed their
own knowledge about clinical research incorrectly.
When the age variable was collapsed (18–24 years and 25–34 years to one group, 18–34
years), the findings indicated that there were more participants among the Generation Y group
and most of them listed themselves as a little knowledgeable (Figure 2); this trend is because
there were only 8 participants under the Generation X category compared to the 201 Generation
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Y participants. No comparison is generalizable with a very small sample size. To get more
accurate or reliable, results for a comparison between these two generations, more participants,
approximately 201, should be enrolled in the 35 and older age group.
In this survey, done in a few classes of HHS and COB, only 38.1% of participants knew
that clinical research is scientific investigations using humans to study treatment of human
disease. The number of correct responses does not increase with academic year, as had been seen
by Garapati (2015). This survey was conducted in undergraduate classes (1–5 classes), and
distribution of the sample was not diverse (among all college years); this has affected the
response trends among participants of HHS and COB. The challenge here is that these results do
not indicate a specific direction or trend. This direction or trend might have been more
significant if the intervention had been more effective with slightly more exposure in the active
group by giving an oral but brief presentation prior to conducting the survey. In the case of
placebo group, students assessed their knowledge incorrectly because of the intervening
paragraph. Garapati (2015) also stated that most of the participants (46.6%) in his survey thought
that clinical research was scientific investigations using laboratory studies to treat human
diseases, but in this survey, the highest number of participants (irrespective of class years,
treatment groups, or academic backgrounds) knew it was done with humans. This could be due
to the structure of the options to this question, where all of the options included “for treating
human disease.” Therefore, for this question, answering correctly could be due to two reasons:
either students had the correct knowledge about clinical trials or they misinterpreted the meaning
of clinical trial. Another interesting finding for above question among the treatment groups is
that 37.6% of the active group answered correctly, and 38.6% of the placebo group answered
correctly. These findings indicate that by percentage, there was not much difference between the
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two treatment groups, though the answer was within the paragraph given to the active group and
not the placebo group, who had no idea. In general, when a survey sheet is given, there is no
assurance that a student has read the paragraph to which they were exposed. Many college
students may simply skip the instructions to finish the survey. Sometimes a group of people may
be exposed to something and not be aware of this exposure. This could be more effective if the
students were asked to read the paragraph aloud, or if it was read aloud to them (by conducting
the survey separately for comparing groups), or if they were asked to circle a few letters or
certain words to ensure that they have absorbed that minimal knowledge and are exposed
properly to the intervention.
When we compare within the treatment groups, 53.2% in the active group and 59% in
placebo group said they would participate in clinical trials. This clearly suggests that the
intervention did not influence the active group to participate in clinical trials. When we compare
the age parameter with willingness to participate, in the active group, all the respondents who
said “yes” are all from Generation Y, and even in the placebo group, 92.7% who said “yes” are
from Generation Y. Though the percentages are higher for willingness to participate in clinical
trials for Generation Y, irrespective of the treatment group, these percentages might have been
more reliable if there had been more participants among the 35 or older group. This is also
because of age diversity at Eastern Michigan University, which has about 19,077 students
between 18 and 34 years and only 2741 who are 35 or older (College Factual, 2016).
According to a survey done by Moorcraft et al. (2016), a majority of subjects participate
in clinical trials because these trials offer the best therapy available and also to help future
generations. But most of the enrolled students in the present survey said that they would
participate in a clinical trial if they got paid. According to Midgley et al. (2016), who
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interviewed all of the adolescents who participated in a multi-center, randomized controlled trial,
the Improving Mood through Psychoanalytic and Cognitive-Behavioural Therapy (IMPACT)
study, 36 of the 76 participants said they participated to help the future generation/others,
whereas 13 of the 76 said they participated to get help with their treatment. One young person
stated that young people should not be paid for participating in the trial, whereas five others
stated that the money paid for taking part in the trial was a source of motivation. In the present
survey, of all the students enrolled, 125 (43.40%) said they would participate in trials if they
were paid, 54 (18.75%) said to help the future generation, and 111 (44.93%) said they would not
participate because they are not sure it would be safe (Table 5).
Luring subjects with monetary compensation is a common practice in clinical research
(Phillips, 2011). But students should be informed that these monetary compensations are not the
only factors to be considered while participating in a clinical trial. Subjects should fall into
suitable inclusion/exclusion criteria to participate in any clinical research study, and it is not
ethical to participate in a clinical trial just for money.
Even in this era where social media such as Facebook, Instagram, and Twitter play a very
important role in any college student’s life, the majority of participants in this survey still
preferred being informed through a physician about any trial they are suitable for. (Figure 6)
Similar to the survey conducted by Garapati (2015), in the present survey, the highest
percentage of participants said that clinical research is done at university medical centers, the
second highest percentage said at hospitals, the third at clinics, and the lowest at private
physicians’ offices. Only 16.19% selected all of the correct responses, and 17.61% indicated that
they are not sure (Table 6).
Similar surveys were conducted in two other colleges (College of Arts and Sciences and
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College of Technology) within the university, by another researcher. These colleges also did not
see a difference between active and placebo groups. This indicates that even in these colleges,
the intervention did not influence the participants’ willingness to volunteer for clinical trials
(Pathakamudi, 2017). These results are therefore independent of the colleges selected and are
found to be more generalized.
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Chapter 6: Conclusion
In conclusion, students’ understanding about clinical research and their willingness to
participate in it were examined using 12 questions within two treatment groups: active and
placebo. In both the College of Health and Human Services and the College of Business, the
intervention used in the survey, that of providing minimal education, did not impact the
willingness of the Generation Y group to participate in clinical trials.
The claim that the intervention would improve the understanding and willingness of
Generation Y to participate in clinical research would be more likely if the comparison group
(i.e., 35 years or older) had an equal sample size. Using strategies such as conducting the survey
separately (for active and placebo groups), reading the paragraph aloud or asking students to
circle certain words, or giving a brief oral presentation prior to the survey and making sure the
students had absorbed all the knowledge would ensure that the exposure was more effective,
which plays a major role in determining accurate and reliable results. Therefore, this survey
provides valuable insight for future researchers considering a wider population and equal sample
size in comparing groups (Generation Y and older age groups). They should also consider doing
a pilot study to understand (or to test assumptions like) the following: whether the education was
adequate, whether we can change minds with written information, whether the assumption that
the information provided in the placebo survey sheet was unknown, and whether cognitive power
plays a role in processing (i.e., reading, understanding, and relating it with the questions) the
given information within the time provided in these kind of surveys.
Limitations of the Research
•

Only a small sample size confined to one university of a single region was evaluated.

•

The sample number in different groups is not equal.
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•

It remains unknown whether any simple educational intervention can change a student's
willingness to participate in clinical studies. Perhaps some of the extended educational
efforts previously noted might have impacted the results.

We can only state that

requiring participants to read a simple statement does not influence willingness to
participate in clinical trials.
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Appendix C: Active Survey Sheet

School of Health Sciences

Please read this paragraph before you answer
Drug development is the process of bringing a new pharmaceutical or medicine to the market. For
pharmaceuticals/medicines to enter the market they have to be first tested in animals and humans.
Clinical research is research done with patients to determine the safety and effectiveness of a new
medicine. Please select the answer(s) that best represents your understanding. Check or
circle all that apply:

Q1. How knowledgeable are you about clinical
research?
a)
b)
c)
d)

Not at all knowledgeable
A little knowledgeable
Somewhat knowledgeable
Completely knowledgeable

Q2. Clinical research or clinical trials are:
a) Scientific investigations using humans to study
treatment of human disease
b) Scientific investigations using animals to study
treatment of human disease
c) Scientific investigations using laboratory studies
to study treatment of human disease
d) Not sure

Q3. If given a chance, would you consider
participating in a clinical research study?
a) Yes

b) No

Q4. I might agree to be in a clinical research study:
a)
b)
c)
d)

If I get paid
To help future generations
Because it might be an interesting thing to do
To get help with my illness

Q5. I might not agree to participate in a research
study:
a) Because I do not want to be used as a guinea pig
in research
b) Because I do not know if it would be safe
c) As I simply prefer not to
d) Because I am concerned about taking an
experimental drug

Q6. Would you take a drug which was not tested in
animal or humans?
a) Yes
b) No

Q7. How would you like to be informed of a
clinical research study you might be appropriate
for?
a)
b)
c)
d)
e)

From my physician
By reading an advertisement
From a government list
From an on campus posting
Through Facebook or other social media

Q8. Where do you think clinical research is
conducted? (Check or circle all that apply)
a)
b)
c)
d)
e)

Hospitals
University Medical Centers
Clinics
Private Physician's Office
Not sure

Q9. I am currently:
a) 18-24 years old
b) 25-34 years old
c) 35 or older

Q10. Female

Male

Prefer not to answer

Q11. My class year is:
a)
b)
c)
d)
e)

First
Second
Third
Fourth
Graduate

Q12. My major is or likely will be in the College of:
a)
b)
c)
d)
e)

Arts & Sciences
Technology
Health & Human Services
Business
Education
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Appendix D: Placebo Survey Sheet

School of Health Sciences

Please read this paragraph before you answer
The scientific method is a body of techniques for investigating phenomena, acquiring new
knowledge, or correcting and integrating previous knowledge. To be termed scientific, a method
of inquiry is commonly based on empirical or measurable evidence subject to specific principles
of reasoning. Please select the answer(s) that best represents your understanding. Check or
circle all that apply:

Q1. How knowledgeable are you about clinical
research?
a)
b)
c)
d)

Not at all knowledgeable
A little knowledgeable
Somewhat knowledgeable
Completely knowledgeable

Q2. Clinical research or clinical trials are:
a) Scientific investigations using humans to study
treatment of human disease
b) Scientific investigations using animals to study
treatment of human disease
c) Scientific investigations using laboratory studies
to study treatment of human disease
d) Not sure

Q3. If given a chance, would you consider
participating in a clinical research study?
a) Yes

b) No

Q4. I might agree to be in a clinical research study:
a)
b)
c)
d)

If I get paid
To help future generations
Because it might be an interesting thing to do
To get help with my illness

Q5. I might not agree to participate in a research
study:
a) Because I do not want to be used as a guinea pig
in research
b) Because I do not know if it would be safe
c) As I simply prefer not to
d) Because I am concerned about taking an
experimental drug

Q6. Would you take a drug which was not tested in
animal or humans?
a) Yes
b) No

Q7. How would you like to be informed of a
clinical research study you might be appropriate
for?
a)
b)
c)
d)
e)

From my physician
By reading an advertisement
From a government list
From an on campus posting
Through Facebook or other social media

Q8. Where do you think clinical research is
conducted? (Check or circle all that apply)
a)
b)
c)
d)
e)

Hospitals
University Medical Centers
Clinics
Private Physician's Office
Not sure

Q9. I am currently:
a) 18-24 years old
b) 25-34 years old
c) 35 or older

Q10. Female

Male

Prefer not to answer

Q11. My class year is:
a)
b)
c)
d)
e)

First
Second
Third
Fourth
Graduate

Q12. My major is or likely will be in the College of:
a)
b)
c)
d)
e)

Arts & Sciences
Technology
Health & Human Services
Business
Education
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Appendix E: Verbal Consent Form

!
!
Informed Consent Form
The personnel in charge of this study are Divya Pandiri, the Principal Investigator and
Shashikiran Pathakamudi, the Co-Principal Investigator. They are graduate students at
Eastern Michigan University. Their faculty adviser is Irwin G. Martin. Throughout this
form, this person will be referred to as the “investigator.”
Purpose of the study
The purpose of this research study is to determine students understanding about health
research.
What will happen if I participate in this study?
Participation in this study involves answering questions related to research, which will
help us to determine college aged students understanding and their attitude towards
research.
What are the anticipated risks for participation?
There are no anticipated physical or psychological risks to participation.
The primary and the only risk of participation in this study is that the student sitting
beside or students among themselves might know they have participated in the study.
Since no names will be collected on the survey sheets there are no identifiers.
Are there any benefits to participating?
You will not directly benefit from participating in this research. You may tend to learn
more about Research.
What are the alternatives to participation?
The alternative is not to participate.
How will my information be kept confidential?
As we are not collecting student names on the survey sheets, your information will
therefore be confidential.
The investigators will also ask you not to tell anyone outside of the class about anything
that was said during the survey. However, we cannot guarantee that everyone will keep
the discussions private.
Approved by the Eastern Michigan University Human Subjects Review Committee
UHSRC Protocol Number: 871645-1
Study Approval Dates: 03/07/16 – 03/06/17
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